Cytokinetics CYTK Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Progress Continues VNET Q4 2025 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Details Remain Unclear Ategrity Specialty Insurance Company Holdings ASIC Q1 2026 Earnings EPS Beats Estimates by 22 Shares Edge Higher Immunovant IMVT Q1 2026 Earnings EPS Miss Driven by Higher RD Investment Stock Holds Steady PBHC Q4 2025 Earnings Negative EPS of 111 Amidst a Challenging Quarter RVLV Q1 2026 Earnings EPS Beats Estimates Stock Rises 42